179 related articles for article (PubMed ID: 11147695)
1. Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events.
Goebel J; Stevens E; Forrest K; Roszman TL
Transpl Immunol; 2000 Nov; 8(3):153-9. PubMed ID: 11147695
[TBL] [Abstract][Full Text] [Related]
2. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling.
Tkaczuk J; Yu CL; Baksh S; Milford EL; Carpenter CB; Burakoff SJ; McKay DB
Am J Transplant; 2002 Jan; 2(1):31-40. PubMed ID: 12095053
[TBL] [Abstract][Full Text] [Related]
4. Intracellular signaling consequences of anti-IL-2Ralpha blockade by daclizumab.
Tkaczuk J; Milford E; Yu C; Baksh S; Carpenter C; Burakoff S; McKay D
Transplant Proc; 2001; 33(1-2):212-3. PubMed ID: 11266783
[No Abstract] [Full Text] [Related]
5. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
6. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
7. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.
Binder M; Vögtle FN; Michelfelder S; Müller F; Illerhaus G; Sundararajan S; Mertelsmann R; Trepel M
Cancer Res; 2007 Apr; 67(8):3518-23. PubMed ID: 17440057
[TBL] [Abstract][Full Text] [Related]
8. Daclizumab: a potential asthma therapy?
Antoniu SA
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):214-21. PubMed ID: 20804450
[TBL] [Abstract][Full Text] [Related]
9. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction.
Liu KD; Lai SY; Goldsmith MA; Greene WC
J Biol Chem; 1995 Sep; 270(38):22176-81. PubMed ID: 7545674
[TBL] [Abstract][Full Text] [Related]
10. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
Swiatecka-Urban A
Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
[TBL] [Abstract][Full Text] [Related]
11. IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipients.
Baan CC; Balk AH; van der Plas AJ; van Gelder T; Vantrimpont PJ; Maat LP; Weimar W
Transplant Proc; 2002 Dec; 34(8):3243-5. PubMed ID: 12493434
[No Abstract] [Full Text] [Related]
12. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.
Gaffen SL; Lai SY; Xu W; Gouilleux F; Groner B; Goldsmith MA; Greene WC
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7192-6. PubMed ID: 7543676
[TBL] [Abstract][Full Text] [Related]
13. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling.
Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW
Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863
[TBL] [Abstract][Full Text] [Related]
14. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
16. Daclizumab therapy in kidney transplantation-different mechanisms of action in- versus ex-vivo?
Forrest K; Logan B; Strange J; Roszman TL; Goebel J
Transpl Immunol; 2005 Mar; 14(1):43-7. PubMed ID: 15814281
[TBL] [Abstract][Full Text] [Related]
17. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
18. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy.
Wuest SC; Edwan JH; Martin JF; Han S; Perry JS; Cartagena CM; Matsuura E; Maric D; Waldmann TA; Bielekova B
Nat Med; 2011 May; 17(5):604-9. PubMed ID: 21532597
[TBL] [Abstract][Full Text] [Related]
19. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
20. Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain.
Delespine-Carmagnat M; Bouvier G; Bertoglio J
Eur J Immunol; 2000 Jan; 30(1):59-68. PubMed ID: 10602027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
